| Literature DB >> 27833633 |
Andrea Kucharíková1, Souvik Kusari2, Selahaddin Sezgin2, Michael Spiteller2, Eva Čellárová1.
Abstract
A plethora of plants belonging to the genus Hypericum have been investigated so far owing to the biological efficacies of pharmacologically important secondary metabolites produced by several Hypericum species. However, there is currently a dearth of information about the localization (accumulation) of these compounds in the plants in situ. In particular, the biosynthetic and ecological consequence of acclimatization of in vitro cultured Hypericum spp. to outdoor conditions is not fully known. Herein, we report an application of matrix-assisted laser desorption/ionization high-resolution mass spectrometry (MALDI-HRMS) to reveal the distribution of major naphthodianthrones hypericin, pseudohypericin, protohypericin, and their proposed precursor emodin as well as emodin anthrone, along with the phloroglucinol derivative hyperforin, the flavonoids quercetin, quercitrin, rutin and hyperoside (and/or isoquercitrin), and chlorogenic acid in Hypericum leaves. Plants encompassing seventeen Hypericum species classified into eleven sections, which were first cultured in vitro and later acclimatized to outdoor conditions, were studied. We focused both on the secretory (dark and translucent glands, other types of glands, and glandular-like structures) as well as the non-secretory leaf tissues. We comparatively analyzed and interpreted the occurrence and accumulation of our target compounds in different leaf tissues of the seventeen species to get an intra-sectional as well as inter-sectional perspective. The naphthodianthrones, along with emodin, were present in all species containing the dark glands. In selected species, hypericin and pseudohypericin accumulated not only in the dark glands, but also in translucent glands and non-secretory leaf tissues. Although hyperforin was localized mainly in translucent glands, it was present sporadically in the dark glands in selected species. The flavonoids quercetin, quercitrin, and hyperoside (and/or isoquercitrin) were distributed throughout the leaves. Rutin was present only within sections Hypericum, Adenosepalum, Ascyreia, and Psorophytum. Our study provides insights into the prospects and challenges of using in vitro cultured Hypericum plants, further adapted to field conditions, for commercial purposes.Entities:
Keywords: Hypericum spp.; inter-sectional; intra-sectional; localization; matrix-assisted laser desorption/ionization high-resolution mass spectrometry; secondary metabolites
Year: 2016 PMID: 27833633 PMCID: PMC5081374 DOI: 10.3389/fpls.2016.01616
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Figure 1Chemical structures of the compounds in the present study.
Occurrence and accumulation of secondary metabolites in the section .
| Adaxial | Dark gland; edge | o | − | + | + | − | + | o | − | + | − | + | |
| Dark gland; inside | o | − | o | − | − | − | − | + | + | − | + | ||
| Translucent gland | o | o | o | − | − | ++ | o | − | + | o | o | ||
| Non-secretory tissue | o | o | − | − | − | − | − | o | + | − | o | ||
| Reddish mass | o | − | − | − | − | − | − | o | + | − | o | ||
| Abaxial | Dark gland; edge | + | o | +++ | +++ | ++ | − | o | + | ++ | + | o | |
| Dark gland; inside | + | o | +++ | +++ | +++ | o | − | + | + | + | o | ||
| Translucent gland | + | o | − | o | − | − | − | o | ++ | o | ++ | ||
| Non-secretory tissue | o | − | o (n) | + (n) | − | − | − | − | + | − | o | ||
| Adaxial | Dark gland; edge | o | − | + | ++ | − | − | − | o | − | − | + | |
| Dark gland; inside | o | − | + | ++ | − | − | − | o | o | − | + | ||
| Translucent gland; edge | o | − | o | + | − | − | − | + | o | − | + | ||
| Translucent gland; inside | o | − | + | ++ | o | − | − | + | + | o | + | ||
| Non-secretory tissue near middle | − | − | − | − | − | − | − | − | − | − | o | ||
| Non-secretory tissue near dark gland; inside | o | − | − | o | − | − | − | o | o | o | o | ||
| Abaxial | Dark gland; edge | + | − | ++ | +++ | ++ | − | + | + | + | o | + | |
| Dark gland; inside | o | − | ++ | ++ | ++ | − | − | + | + | o | o | ||
| Translucent gland; edge | o | − | − | − | − | − | − | − | + | + | + | ||
| Translucent gland; inside | + | o | − | o | − | − | − | − | o | o | o | ||
| Non-secretory tissue; edge | o | − | − | − | − | − | − | − | o | − | + | ||
| Non-secretory tissue near dark gland; inside | o | − | o | + | o | − | − | o | o | o | + | ||
| Adaxial | Dark gland | − | − | + | + | o | − | − | o | o | − | + | |
| Red gland 1 | − | − | − | − | − | − | − | − | − | + | o | ||
| Red gland 2 | + | − | − | − | − | − | − | − | − | − | o | ||
| Red gland 3 | − | − | − | − | − | − | − | − | − | + | o | ||
| Non-secretory tissue; edge | o | − | − | − | − | − | − | o | o | − | o | ||
| Abaxial | Big dark gland | o | − | +++ | +++ | ++ | − | + | + | o | + | + | |
| Small dark gland | + | − | ++ | + | − | − | − | − | − | − | o | ||
| Red gland 1; edge | + | o | − | − | − | − | − | + | ++ | + | + | ||
| Red gland 2; edge | + | + | ++(d) | ++(d) | − | − | − | ++ | ++ | + | + | ||
| Non-secretory tissue; edge | + | − | − | − | − | − | − | − | o | − | o | ||
| Non-secretory tissue; inside | + | o | − | − | − | − | − | − | o | − | o | ||
| Adaxial | Dark gland; edge | + | o | + | + | o | − | − | ++ | ++ | + | + | |
| Translucent gland | o | − | +(n) | +(n) | − | − | − | + | + | + | + | ||
| Reddish dark gland | + | o | ++ | +++ | ++ | − | − | + | ++ | + | + | ||
| Unidentified red mass | o | − | o | o | − | − | − | o | ++ | o | + | ||
| Non-secretory tissue | o | − | − | o (n) | − | − | − | o | + | + | o | ||
| Abaxial | Dark gland; edge | ++ | + | +++ | +++ | +++ | − | − | + | ++ | + | o | |
| Dark gland; inside | ++ | + | +++ | +++ | ++ | − | − | ++ | ++ | + | − | ||
| Non-secretory tissue | − | − | − | − | − | − | − | − | − | − | − | ||
The values are represented as absolute mean signal intensities. +++, > 1E5 (highest); ++, 1E4-9E4; +, 1E3-9E3; o, 5E2-9E2 (lowest); −, not detected; n, non-continuous signal over measurement time; d, detected after long/optimized penetration with laser (> 2.5 min).
Occurrence and accumulation of secondary metabolites in the sections .
| Adaxial | Dark gland; edge | + | − | ++ | +++ | + | − | − | o (n) | + | + | − | |
| Dark gland; inside | + | o | +++ | +++ | +++ | − | o | ++ | ++ | ++ | o | ||
| Non-secretory tissue | − | − | − | − | − | − | − | − | − | − | − | ||
| Abaxial | Dark gland; edge | + | o | +++ | +++ | +++ | − | − | ++ | ++ | ++ | o | |
| Dark gland; inside | − | − | + | + | − | − | − | − | − | + | − | ||
| Non-secretory tissue | − | − | − | − | − | − | − | − | − | − | − | ||
| Adaxial | Dark gland; edge | o | o | + | + | − | − | − | o | + | o | + | |
| Dark gland; inside | − | o | o | o | − | − | − | o | + | − | + | ||
| Translucent gland | o | − | − | − | − | − | − | + | + | + | o | ||
| Non-secretory tissue | o | − | − | − | − | − | − | o | + | o | o | ||
| Abaxial | Dark gland; edge | + | + | +++ | +++ | +++ | − | − | + | ++ | + | o | |
| Translucent gland | + | − | − | o (n) | − | − | − | o | +++ | o | ++ | ||
| Non-secretory tissue | o | o | − | o (n) | − | − | − | o (n) | ++ | o (n) | + | ||
| Adaxial | Dark gland; edge | − | − | o | − | − | − | − | − | o | − | − | |
| Dark gland; inside | − | − | o | − | − | − | − | − | − | − | − | ||
| Translucent gland | o | − | − | o | − | − | o | o | o | o | − | ||
| Unidentified red spots; edge | − | − | o | o | − | − | − | − | o | + | − | ||
| Non-secretory tissue | − | − | − | − | − | − | − | − | − | − | − | ||
| Abaxial | Dark gland, reddish; edge | + | − | +++ | +++ | ++ | − | o | + | ++ | + | o | |
| Dark gland; inside | o | − | + | ++ | o | − | o | − | + | o | − | ||
| Translucent gland | − | − | − | − | − | − | o | − | o | − | − | ||
| Unidentified reddish/orange spot 1; inside | − | − | − | − | − | − | − | − | − | − | − | ||
| Unidentified reddish/orange spot 2; inside | − | − | − | − | − | − | − | − | o | − | − | ||
| Non-secretory tissue | − | − | − | − | − | − | − | − | − | − | − | ||
| Adaxial | Dark gland; edge | − | − | o | o | − | − | − | − | − | + | − | |
| Dark gland; inside | − | − | − | − | − | − | − | − | − | − | − | ||
| Translucent gland | − | − | − | − | − | − | − | − | − | − | − | ||
| Non-secretory tissue | − | − | − | o | − | − | − | − | − | − | − | ||
| Abaxial | Dark gland; edge | ++ | + | +++ | +++ | +++ | − | − | + | ++ | ++ | + | |
| Translucent gland | o | − | − | − | − | − | − | − | + | + | o | ||
| Non-secretory tissue | − | − | − | − | − | − | − | − | o | − | − | ||
The values are represented as absolute mean signal intensities. +++, > 1E5 (highest); ++, 1E4-9E4; +, 1E3-9E3; o, 5E2-9E2 (lowest); −, not detected; n, non-continuous signal over measurement time; d, detected after long/optimized penetration with laser (> 2.5 min).
Occurrence and accumulation of secondary metabolites in the sections .
| Adaxial | Translucent gland; edge | − | − | − | − | − | − | − | − | − | − | o | |
| Non-secretory tissue; edge | − | − | − | − | − | − | − | − | + | − | o | ||
| Non-secretory tissue; inside | − | − | − | − | − | − | − | o | + | − | o | ||
| Abaxial | Translucent gland; edge | − | − | − | − | − | − | − | − | + | o | o | |
| Translucent gland; inside | − | − | − | − | − | o (d) | − | − | + | o | o | ||
| Non-secretory tissue; edge | − | − | − | − | − | − | − | − | − | − | − | ||
| Non-secretory tissue; inside | − | − | − | − | − | − | − | − | − | − | − | ||
| Adaxial | Translucent gland; edge | o | − | o | − | − | − | − | + | ++ | + | o | |
| Non-secretory tissue; inside | − | − | − | − | − | − | − | − | + | − | − | ||
| Abaxial | Translucent gland; edge | o | − | o | − | − | o (n) | − | o | + | + | o | |
| Translucent gland; inside | o | − | − | − | − | − | − | + | + | + | − | ||
| Unidentified black masses | o | − | − | − | − | − | − | − | + | + | o | ||
| Non-secretory tissue; edge | − | − | − | − | − | − | − | − | + | + | o | ||
| Non-secretory tissue; inside | o | o (n) | − | − | − | − | − | o | + | + | − | ||
| Adaxial | Translucent gland; edge | − | − | − | − | − | − | − | − | o | o | − | |
| Translucent gland; inside | − | − | − | − | − | − | − | − | − | o | − | ||
| Translucent gland; inside | − | − | − | − | − | − | − | − | − | − | − | ||
| Non-secretory tissue; edge | − | o (n) | − | − | − | − | − | − | o | + | − | ||
| Non-secretory tissue; inside | − | − | − | − | − | − | − | − | − | − | − | ||
| Abaxial | Translucent gland; edge | − | − | − | − | − | − | − | − | + | + | − | |
| Unidentified black dot-like structure | o | − | − | − | − | ++ | o | o | ++ | + | o (n) | ||
| Unidentified gland; near the central vein | − | − | − | − | − | o | − | − | − | − | o (n) | ||
| Non-secretory tissue; edge | o | − | − | − | − | − | o | o | o | + | − | ||
| Adaxial | Translucent gland; edge | o | − | − | − | − | ++ | − | − | + | o | o | |
| Translucent gland 1; inside | o | − | − | − | − | ++ | − | − | + | o | o | ||
| Translucent gland 2; inside | o | o | − | − | − | + (d) | − | − | o | o | + | ||
| Non-secretory tissue; edge | − | − | − | − | − | − | − | − | − | − | + | ||
| Non-secretory tissue; inside | o | − | − | − | − | − | − | o | o | o | − | ||
| Abaxial | Translucent gland; edge | o | − | − | − | − | ++ | − | − | − | − | + | |
| Translucent gland; inside | − | − | − | − | − | − | − | − | o | − | o | ||
| Translucent gland | + | − | o | o | − | ++ | − | − | + | o | + | ||
| Non-secretory tissue; edge | o | o | − | − | − | − | − | − | − | − | + | ||
| Non-secretory tissue; inside | o | + (n) | − | − | − | − | − | − | − | − | + | ||
The values are represented as absolute mean signal intensities. +++, > 1E5 (highest); ++, 1E4-9E4; +, 1E3-9E3; o, 5E2-9E2 (lowest); −, not detected; n, non-continuous signal over measurement time; d, detected after long/optimized penetration with laser (> 2.5 min).
Occurrence and accumulation of secondary metabolites in the sections .
| Adaxial | Translucent gland; edge | − | − | − | − | − | − | − | − | o | o | − | |
| Translucent gland; inside | − | − | − | − | − | − | − | − | o | − | − | ||
| Non-secretory tissue; edge | − | − | − | − | − | − | − | − | − | − | − | ||
| Non-secretory tissue; inside | − | − | − | − | − | − | − | − | + | − | − | ||
| Abaxial | Translucent gland; edge | − | − | − | − | − | − | − | + | + | + | − | |
| Non-secretory tissue; edge | − | − | − | − | − | − | − | − | − | − | − | ||
| Non-secretory tissue; inside | − | − | − | − | − | − | − | − | − | − | − | ||
| Adaxial | Unidentified gland; edge | − | − | − | − | − | − | − | o (n) | − | + | − | |
| Unidentified gland; inside | − | ++ (n) | − | − | − | − | − | − | − | o | o | ||
| Non-secretory tissue; edge | − | − | − | − | − | − | − | − | − | − | − | ||
| Non-secretory tissue; inside | − | + (n) | − | − | − | − | − | − | + | − | |||
| Abaxial | Unidentified gland; edge | − | − | − | − | − | − | − | o (n) | o | + | − | |
| Unidentified gland; inside | − | o | − | − | − | − | o | − | + | − | o | ||
| Non-secretory tissue; edge | − | − | − | − | − | − | − | − | − | − | − | ||
| Non-secretory tissue; inside | − | − | − | − | − | − | − | − | − | − | − | ||
| Adaxial | Translucent gland; edge | − | − | − | − | − | − | − | − | + | − | o | |
| Translucent gland; inside | − | − | − | − | − | − | − | o | + | o | + | ||
| Non-secretory tissue; edge | − | − | − | − | − | − | − | + | + | + | + | ||
| Non-secretory tissue; inside | − | − | − | − | − | − | − | − | − | − | o | ||
| Abaxial | Translucent gland; edge | − | − | − | − | − | − | − | − | ++ | − | o | |
| Unidentified dark mass; near the central vein | o | − | − | − | − | − | − | − | − | − | + | ||
| Translucent gland | − | − | − | − | − | + | − | − | ++ | − | o | ||
| Non-secretory tissue; edge | − | − | − | − | − | − | − | − | + | − | + | ||
| Non-secretory tissue; inside | − | − | − | − | − | − | − | − | + | − | + | ||
The values are represented as absolute mean signal intensities. +++, > 1E5 (highest); ++, 1E4-9E4; +, 1E3-9E3; o, 5E2-9E2 (lowest); −, not detected; n, non-continuous signal over measurement time; d, detected after long/optimized penetration with laser (> 2.5 min).
Occurrence and accumulation of secondary metabolites in the sections .
| Adaxial | Unidentified orange spot | o (n) | − | − | − | − | − | − | − | + | − | − | |
| Unidentified brown spot; top | o (n) | − | o (n) | − | − | − | − | o | o | o | − | ||
| Unidentified brown spot; bottom | − | − | o (n) | − | − | − | − | o | + | o | − | ||
| Non-secretory tissue | − | − | − | − | − | − | − | − | − | − | − | ||
| Abaxial | Unidentified gland 1 | o (n) | − | o (n) | − | − | − | − | − | o | − | o | |
| Unidentified gland 2 | o (n) | − | o (n) | o (n) | − | − | − | o | o | o | o | ||
| Unidentified gland 3 | − | − | o (n) | o (n) | − | − | − | − | + | − | o | ||
| Non-secretory tissue | − | − | − | − | − | − | − | − | − | − | − | ||
| Adaxial | Translucent gland | o | − | o | o | − | − | − | + | + | o | + | |
| Unidentified red spot | o | − | o | o | − | − | − | + | + | o | o | ||
| Unidentified red spot; inside | − | − | − | − | − | − | − | o | − | − | − | ||
| Non-secretory tissue | − | − | − | − | − | − | − | o | o | − | − | ||
| Abaxial | Translucent gland | − | − | − | − | − | − | − | − | − | o | − | |
| Reddish mass around translucent gland | − | − | − | − | − | − | − | − | − | − | o | ||
| Unidentified black dot; inside | − | − | o | o | − | − | − | − | − | o | − | ||
| Unidentified brownish mass; inside | − | − | + | + | − | − | − | − | − | + | − | ||
| Non-secretory tissue | − | − | − | − | − | − | − | − | − | − | − | ||
The values are represented as absolute mean signal intensities. +++, > 1E5 (highest); ++, 1E4-9E4; +, 1E3-9E3; o, 5E2-9E2 (lowest); −, not detected; n, non-continuous signal over measurement time; d, detected after long/optimized penetration with laser (> 2.5 min).